Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy

Autor: Jen, Wei-Ying, Sasaki, Koji, Ravandi, Farhad, Kadia, Tapan M., Wang, Sa A., Wang, Wei, Loghavi, Sanam, Daver, Naval, DiNardo, Courtney D., Issa, Ghayas C., Abbas, Hussein A., Nasnas, Cedric, Bataller, Alex, Urrutia, Samuel, Karrar, Omer S., Pierce, Sherry, Kantarjian, Hagop M., Short, Nicholas J.
Zdroj: In Blood Advances November 2024
Databáze: ScienceDirect